| Literature DB >> 18231957 |
Masahito Hibi1, Hibi Masahito, Fujio Hara, Hirokazu Tomishige, Yoshihisa Nishida, Takazumi Kato, Naotake Okumura, Takashi Hashimoto, Ryoichi Kato.
Abstract
Humoral hypercalcemia of malignancy (HHM) is a rare complication of malignant pediatric tumors, specifically those that secrete humoral factor(s), such as parathyroid hormone-related peptide (PTHrP). The authors report a case of severe hypercalcemia associated with ovarian dysgerminoma in a 10-year-old girl. In this case, the humoral factor was considered to be 1,25-dihydroxyvitamin D. HHM is extremely resistant to medical therapy. Therefore, tumor resection or volume reduction is necessary to control serum calcium levels.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18231957 DOI: 10.1080/08880010701774033
Source DB: PubMed Journal: Pediatr Hematol Oncol ISSN: 0888-0018 Impact factor: 1.969